Massachusetts General Hospital: Pancreatic Neoplasms trials

The registry lists 21 Pancreatic Neoplasms studies with Massachusetts General Hospital as lead sponsor. 2 are open to participants now and 9 have results posted.

Phase 1 4Phase 2 13Phase 3 1Phase 4 1No phase 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Vilastobart+Retifanlimab in BRCA or PALB2 Deficient PCNot yet recruitingNCT07765836Phase 2
• Evaluation of PET Probe [68Ga]CBP8 in the Detection of Radiation Induced Tissue InjuryRecruitingNCT04485286Phase 2
• Niraparib + Dostarlimab + RT in Pancreatic CancerCompletedNCT04409002Phase 2Results posted
• Phase II Study of Preoperative FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel in Patients With Resectable Pancreatic CancerTerminatedNCT02243007Phase 2Results posted
• Radiation w/FOLFIRINOX-Losartan for Pancreatic CancerCompletedNCT01821729Phase 2Results posted
• FOLFIRINOX + RT for Pancreatic CancerCompletedNCT01591733Phase 2Results posted
• Short Course Radiation Therapy With Proton or Photon Beam Capecitabine and Hydroxychloroquine for Resectable Pancreatic CancerCompletedNCT01494155Phase 2Results posted
• Pre-Operative Staging of Pancreatic Cancer Using Superparamagnetic Iron Oxide Magnetic Resonance Imaging (SPIO MRI)CompletedNCT00920023Phase 4Results posted
• Neoadjuvant Accelerated Short Course Radiation Therapy With Proton Beam and Capecitabine for Resectable Pancreatic CancerCompletedNCT00438256Phase 1/2Results posted
• Escitalopram in Treating Depression in Patients With Advanced Lung or Gastrointestinal CancerTerminatedNCT00387348Phase 3Results posted
• Gemcitabine, Bevacizumab and Erlotinib in Pancreatic CancerCompletedNCT00366457Phase 2Results posted
• Predicting Disease Progression and/or Recurrence in CancerCompletedNCT04776837
• Supportive Oncology Care At Home RCTActive, not recruitingNCT04544046Not applicable
• Nivolumab + Ipilimumab + Radiation in MSS Pancreatic CancerActive, not recruitingNCT04361162Phase 2
• Supportive Oncology Care at Home for Patients With Pancreatic Cancer Receiving Preoperative FOLFIRINOXCompletedNCT03798769Not applicable
• Electron Beam Intraoperative Radiation Therapy Following Chemoradiation in Patients With Pancreatic Cancer With Vascular InvolvementActive, not recruitingNCT03716531Not applicable
• Losartan and Nivolumab in Combination With FOLFIRINOX and SBRT in Localized Pancreatic CancerActive, not recruitingNCT03563248Phase 2
• Nivolumab and Ipilimumab and Radiation Therapy in MSS and MSI High Colorectal and Pancreatic CancerActive, not recruitingNCT03104439Phase 2
• LDE225 With Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan for Untreated Advanced Pancreatic CancerCompletedNCT01485744Phase 1
• Temsirolimus in Combination With Gemcitabine in Previously Untreated Metastatic Pancreatic CancerTerminatedNCT00593008Phase 1
• Study of Bevacizumab in Combination With 5-FU, Oxaliplatin and External Beam Radiation Followed by Gemcitabine and Bevacizumab for Locally Advanced Pancreatic CancerTerminatedNCT00307723Phase 1/2